{"id":"https://openalex.org/W84312996","doi":"https://doi.org/10.1097/00004872-199816120-00018","title":"Quality of life and calcium channel blockade with nifedipine GITS versus amlodipine in hypertensive patients in Spain","display_name":"Quality of life and calcium channel blockade with nifedipine GITS versus amlodipine in hypertensive patients in Spain","publication_year":1998,"publication_date":"1998-12-01","ids":{"openalex":"https://openalex.org/W84312996","doi":"https://doi.org/10.1097/00004872-199816120-00018","mag":"84312996","pmid":"https://pubmed.ncbi.nlm.nih.gov/9869019"},"language":"en","primary_location":{"id":"doi:10.1097/00004872-199816120-00018","doi":"https://doi.org/10.1097/00004872-199816120-00018","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004872-199816120-00018","pdf_url":null,"source":{"id":"https://openalex.org/S115964404","display_name":"Journal of Hypertension","issn_l":"0263-6352","issn":["0263-6352","1473-5598"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Hypertension","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060217385","display_name":"Marcia A. Testa","orcid":"https://orcid.org/0000-0003-0139-2176","observed_orcids":["https://orcid.org/0000-0003-0139-2176"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marcia A. Testa","raw_affiliation_strings":["Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, USA","institution_ids":["https://openalex.org/I136199984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113600461","display_name":"Ralph R. Turner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Ralph R. Turner","raw_affiliation_strings":["Phase V Technologies, Inc., Wellesley Hills, Massachusetts, USA","and requests for reprints to Dr Ralph R. Turner, Phase V Technologies, Inc., 20 Walnut Street, Suite 110, Wellesley Hills, MA 02481-2104, USA. Tel: +1 781 237 7737; fax: +1 781 237 4407; E-mail","E-mail","fax: +1 781 237 4407","requests for reprints to Dr Ralph R. Turner, Phase V Technologies, Inc., 20 Walnut Street, Suite 110, Wellesley Hills, MA 02481-2104, USA. Tel: +1 781 237 7737"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phase V Technologies, Inc., Wellesley Hills, Massachusetts, USA","institution_ids":[]},{"raw_affiliation_string":"and requests for reprints to Dr Ralph R. Turner, Phase V Technologies, Inc., 20 Walnut Street, Suite 110, Wellesley Hills, MA 02481-2104, USA. Tel: +1 781 237 7737; fax: +1 781 237 4407; E-mail","institution_ids":[]},{"raw_affiliation_string":"E-mail","institution_ids":[]},{"raw_affiliation_string":"fax: +1 781 237 4407","institution_ids":[]},{"raw_affiliation_string":"requests for reprints to Dr Ralph R. Turner, Phase V Technologies, Inc., 20 Walnut Street, Suite 110, Wellesley Hills, MA 02481-2104, USA. Tel: +1 781 237 7737","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083651022","display_name":"Donald C. Simonson","orcid":"https://orcid.org/0000-0002-4670-6290","observed_orcids":["https://orcid.org/0000-0002-4670-6290"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Donald C. Simonson","raw_affiliation_strings":["Phase V Technologies, Inc., Wellesley Hills, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phase V Technologies, Inc., Wellesley Hills, Massachusetts, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053658877","display_name":"Mary Beth Krafcik","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mary Beth Krafcik","raw_affiliation_strings":["Phase V Technologies, Inc., Wellesley Hills, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Phase V Technologies, Inc., Wellesley Hills, Massachusetts, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101809805","display_name":"Carlos Calvo","orcid":"https://orcid.org/0000-0002-3721-5414","observed_orcids":["https://orcid.org/0000-0002-3721-5414"]},"institutions":[{"id":"https://openalex.org/I2799747612","display_name":"Xunta de Galicia","ror":"https://ror.org/0181xnw06","country_code":"ES","type":"government","lineage":["https://openalex.org/I2799747612"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Carlos Calvo","raw_affiliation_strings":["Xeral de Galicia, Santiago de Compostela, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Xeral de Galicia, Santiago de Compostela, Spain","institution_ids":["https://openalex.org/I2799747612"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062327357","display_name":"Manuel Luque-Otero","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2961216182","display_name":"Hospital Cl\u00ednico San Carlos","ror":"https://ror.org/04d0ybj29","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2961216182","https://openalex.org/I4210139293"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Manuel Luque-Otero","raw_affiliation_strings":["Hospital Clinico, Madrid, Spain","Sponsorship: This study was supported in part by a grant (R01 HS07767) from the Agency for Health Care Policy Research (M.A.T). The clinical study was funded by a grant from Quimica Farmaceutics Bayer, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Clinico, Madrid, Spain","institution_ids":["https://openalex.org/I2961216182"]},{"raw_affiliation_string":"Sponsorship: This study was supported in part by a grant (R01 HS07767) from the Agency for Health Care Policy Research (M.A.T). The clinical study was funded by a grant from Quimica Farmaceutics Bayer, Madrid, Spain","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5113600461"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.2519,"has_fulltext":false,"cited_by_count":41,"citation_normalized_percentile":{"value":0.88690794,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"16","issue":"12","first_page":"1839","last_page":"1847"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10924","display_name":"Cardiovascular Health and Disease Prevention","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.8740000128746033},{"id":"https://openalex.org/keywords/nifedipine-gits","display_name":"nifedipine GITS","score":0.8289999961853027},{"id":"https://openalex.org/keywords/amlodipine","display_name":"amlodipine","score":0.996999979019165},{"id":"https://openalex.org/keywords/calcium-channel-blockers","display_name":"calcium channel blockers","score":0.9850000143051147},{"id":"https://openalex.org/keywords/health-related-quality-of-life","display_name":"health-related quality of life","score":0.8830000162124634},{"id":"https://openalex.org/keywords/extended-release-formulation","display_name":"sustained-release formulation","score":0.5630000233650208},{"id":"https://openalex.org/keywords/once-daily-dosing","display_name":"once-daily dosing","score":0.9089999794960022},{"id":"https://openalex.org/keywords/blood-pressure-reduction","display_name":"blood pressure reduction","score":0.7699999809265137},{"id":"https://openalex.org/keywords/sleep-disturbance","display_name":"sleep disorders","score":0.7459999918937683},{"id":"https://openalex.org/keywords/cognitive-function","display_name":"cognitive function","score":0.5680000185966492},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.4819999933242798},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5889999866485596},{"id":"https://openalex.org/keywords/mild-to-moderate-hypertension","display_name":"mild to moderate hypertension","score":0.7110000252723694},{"id":"https://openalex.org/keywords/spain","display_name":"Spain","score":0.9919999837875366}],"concepts":[{"id":"https://openalex.org/C2779646130","wikidata":"https://www.wikidata.org/wiki/Q411347","display_name":"Amlodipine","level":3,"score":0.9673514366149902},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9304031133651733},{"id":"https://openalex.org/C2779066535","wikidata":"https://www.wikidata.org/wiki/Q39111","display_name":"Nifedipine","level":3,"score":0.8375589847564697},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.7737403512001038},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.5156996846199036},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5124726891517639},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.44028759002685547},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4283132553100586},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.41611552238464355},{"id":"https://openalex.org/C2780356492","wikidata":"https://www.wikidata.org/wiki/Q421700","display_name":"Calcium channel blocker","level":3,"score":0.4153679609298706},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.37503722310066223},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.3511759042739868},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3340189754962921},{"id":"https://openalex.org/C519063684","wikidata":"https://www.wikidata.org/wiki/Q706","display_name":"Calcium","level":2,"score":0.12340566515922546},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002121","descriptor_name":"Calcium Channel Blockers","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002121","descriptor_name":"Calcium Channel Blockers","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009543","descriptor_name":"Nifedipine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009543","descriptor_name":"Nifedipine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D009543","descriptor_name":"Nifedipine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D013030","descriptor_name":"Spain","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016503","descriptor_name":"Drug Delivery Systems","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D017311","descriptor_name":"Amlodipine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017311","descriptor_name":"Amlodipine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017311","descriptor_name":"Amlodipine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/00004872-199816120-00018","doi":"https://doi.org/10.1097/00004872-199816120-00018","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004872-199816120-00018","pdf_url":null,"source":{"id":"https://openalex.org/S115964404","display_name":"Journal of Hypertension","issn_l":"0263-6352","issn":["0263-6352","1473-5598"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Hypertension","raw_type":"journal-article"},{"id":"pmid:9869019","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9869019","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of hypertension","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G4045976235","display_name":null,"funder_award_id":"R01 HS07767","funder_id":"https://openalex.org/F4320332177","funder_display_name":"Agency for Healthcare Research and Quality"}],"funders":[{"id":"https://openalex.org/F4320332177","display_name":"Agency for Healthcare Research and Quality","ror":"https://ror.org/03jmfdf59"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W34384985","https://openalex.org/W945982950","https://openalex.org/W1968377352","https://openalex.org/W1975285483","https://openalex.org/W1975653633","https://openalex.org/W1990683886","https://openalex.org/W1993351502","https://openalex.org/W2001877243","https://openalex.org/W2006015406","https://openalex.org/W2034894486","https://openalex.org/W2044124075","https://openalex.org/W2045265325","https://openalex.org/W2074230530","https://openalex.org/W2079285987","https://openalex.org/W2081248103","https://openalex.org/W2119369921","https://openalex.org/W2127144876","https://openalex.org/W2129671736","https://openalex.org/W2138090360","https://openalex.org/W2138461535","https://openalex.org/W2145144040","https://openalex.org/W2319337721","https://openalex.org/W2320007718","https://openalex.org/W2332694193","https://openalex.org/W2396595108","https://openalex.org/W2410193755","https://openalex.org/W4238900290","https://openalex.org/W4238980566","https://openalex.org/W4242459468","https://openalex.org/W4255345540"],"related_works":["https://openalex.org/W2098693685","https://openalex.org/W2372875632","https://openalex.org/W2327229660","https://openalex.org/W2075550002","https://openalex.org/W2410193755","https://openalex.org/W2390721316","https://openalex.org/W2408907824","https://openalex.org/W1995216797","https://openalex.org/W780987184","https://openalex.org/W2617479000"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Compliance":[1],"with":[2,114,174],"hypertension":[3,118],"treatment":[4,153],"is":[5,286,292],"affected":[6],"by":[7,33],"treatment-related":[8],"factors":[9],"(complexity,":[10],"side":[11],"effects),":[12],"efficacy":[13],"and":[14,48,64,78,87,110,130,134,194,215,235,238,261,291],"compound-specific":[15,268],"effects":[16,269,328],"that":[17,274],"impact":[18],"on":[19,270,329],"quality":[20,29,137,271],"of":[21,30,138,205,229,272,305],"life.":[22],"This":[23,51],"study":[24,95],"examined":[25],"the":[26,141,156,281],"differences":[27,150,279],"in":[28,98,102,128,135,155,186,202,226,240,251,280],"life":[31,139,273],"produced":[32],"two":[34],"once-daily":[35],"calcium":[36,175],"channel":[37,176],"blockers":[38],"using":[39],"different":[40],"delivery":[41,282],"systems:":[42],"nifedipine":[43,60,163,182],"gastrointestinal":[44],"therapeutic":[45],"system":[46],"(GITS)":[47],"amlodipine.":[49],"DESIGN:":[50],"was":[52,96,320],"a":[53,72,196,296,303,316],"double-blind,":[54],"double-dummy,":[55],"randomized":[56,112],"clinical":[57],"trial":[58],"comparing":[59],"GITS":[61,164,183,285],"(30":[62],"mg)":[63,67],"amlodipine":[65,167,201,223,301,324],"(5":[66],"for":[68,322],"24":[69,297],"weeks":[70],"following":[71],"placebo":[73],"run-in.":[74],"Clinical,":[75],"laboratory":[76],"evaluations":[77],"quality-of-life":[79,188],"data":[80],"were":[81,140,147,178],"assessed":[82],"at":[83],"screening,":[84],"baseline":[85],"randomization":[86],"three":[88],"times":[89],"during":[90],"active":[91,152],"therapy.":[92],"SETTING:":[93],"The":[94,105,181,222],"conducted":[97],"13":[99],"medical":[100],"clinics":[101],"Spain.":[103],"PATIENTS:":[104],"sample":[106],"comprised":[107],"430":[108],"screened":[109],"356":[111],"patients":[113],"mild":[115],"to":[116,278],"moderate":[117],"(diastolic":[119],"blood":[120,132,157,161],"pressure":[121,133,158],"95-114":[122],"mmHg).":[123,169],"MAIN":[124],"OUTCOME":[125],"MEASURES:":[126],"Change":[127],"systolic":[129],"diastolic":[131],"health-related":[136],"main":[142],"outcome":[143],"measures.":[144],"RESULTS:":[145],"There":[146],"no":[148],"significant":[149],"between":[151],"groups":[154],"changes":[159],"(systolic":[160],"pressure:":[162],"-15.5":[165],"mmHg;":[166],"-15.7":[168],"Spontaneous":[170],"adverse":[171],"events":[172],"consistent":[173],"blockage":[177],"not":[179],"different.":[180],"group":[184,224,249],"improved":[185,250],"all":[187],"measures":[189],"except":[190],"Sexual":[191,241],"Symptom":[192,242],"Distress":[193,243],"showed":[195],"significantly":[197,239],"greater":[198],"improvement":[199],"than":[200],"overall":[203,227],"Quality":[204,228],"Life":[206],"(P<":[207],"0.05),":[208],"General":[209,231],"Perceived":[210,232],"Health":[211],"(P":[212,219,244,258],"<":[213,220,245,259],"0.026)":[214],"its":[216],"subscale":[217],"Vitality":[218,234],"0.019).":[221],"declined":[225],"Life,":[230],"Health,":[233],"Sleep":[236],"Disturbance,":[237],"0.045).":[246],"However,":[247],"this":[248],"self-reported":[252],"Cognitive":[253],"Functioning":[254],"(P=0.036),":[255],"Mental":[256],"Acuity":[257],"0.005)":[260],"Detachment/disorientation":[262],"(P=0.01).":[263],"CONCLUSIONS:":[264],"These":[265],"results":[266],"suggest":[267],"may":[275,309],"be":[276],"due":[277],"system.":[283],"Nifedipine":[284],"short-acting":[287],"(2":[288],"h":[289,298],"half-life)":[290],"delivered":[293],"continuously":[294],"over":[295],"period,":[299],"while":[300],"has":[302],"half-life":[304],"40":[306],"h,":[307],"which":[308],"produce":[310],"more":[311,317],"sustained":[312],"low-level":[313],"effects.":[314],"While":[315],"beneficial":[318],"profile":[319],"observed":[321],"nifedipine,":[323],"demonstrated":[325],"potential":[326],"positive":[327],"cognitive":[330],"functioning.":[331]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}